Dr. Alok Uprety, MD

Dr. Uprety practices at Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System.

Dr. Uprety's NPI, 1205357852, was assigned on July 5, 2017. Dr. Uprety holds Indiana license 01083740.

Dr. Uprety's primary practice is Parkview Regional Medical Center, at 11109 Parkview Plaza Drive, Fort Wayne, IN 46845 in Allen County. The practice phone is (260) 266-1195.

Dr. Uprety's primary practice is Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System. Dr. Uprety is also affiliated with Parkview Huntington Hospital. The medical group on file is Parkview Physicians Group. Dmand AI also links Dr. Uprety to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uprety practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Uprety's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Uprety's licenses on file in 2 states: Indiana and Illinois.

CMS data shows 529 Medicare services from Dr. Uprety across 5 procedure codes in 2024, for 225 Medicare patients. Medicare paid $44,434 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 225 Medicare patients who saw Dr. Uprety in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Uprety's median patient age at 74, with 52% women.

In 2024, Dr. Uprety wrote 287 Medicare Part D claims for 143 patients. 86% of them were for generic drugs. CMS names the drug for 71 of them, across 4 drugs with 11 or more claims each, at $21,286 in total drug cost. In 2023, CMS named 62 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Uprety for performance year 2024, reported as part of a group. Dr. Uprety accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Uprety, published from 2019 to 2020. 2020 was the busiest year, with 2. Dr. Uprety's most frequent co-authors are Tauseef Akhtar, MD, Setri S. Fugar, MD and Shweta Gupta, MD.

CMS Open Payments shows 2 general payments to Dr. Uprety from 1 drug or device company from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $34.